H2020 and beyond: Skip discrepancy between theory and practice of personalized medicine. a position paper by the Italian society of personalized medicine

Marina Borro, Maurizio Simmaco, Antonio Aceti, Sandro Barni, Assunta De Luca, Vittorio Fineschi, Paola Frati, P. Girardi, Monica Rosa Miozzo, Giulio Nati, Ferdinando Nicoletti, Daniele Santini, Paolo Marchetti

Research output: Contribution to journalArticle

Abstract

Many unsolved practical issues, from technical and scientific to ethical, legal and economic topics, are slowing down the translation of Personalized Medicine principles into medical practice. The Italian Society of Personalized Medicine exposes here its point of view, based on the real-world practice of precision medicine carried-out in Italian healthcare structures.

Original languageEnglish
Pages (from-to)926-929
Number of pages4
JournalCurrent Pharmaceutical Biotechnology
Volume17
Issue number10
Publication statusPublished - Aug 1 2016

Keywords

  • H2020
  • Personalized medicine
  • Precision medicine

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Biotechnology

Fingerprint Dive into the research topics of 'H2020 and beyond: Skip discrepancy between theory and practice of personalized medicine. a position paper by the Italian society of personalized medicine'. Together they form a unique fingerprint.

  • Cite this

    Borro, M., Simmaco, M., Aceti, A., Barni, S., De Luca, A., Fineschi, V., Frati, P., Girardi, P., Miozzo, M. R., Nati, G., Nicoletti, F., Santini, D., & Marchetti, P. (2016). H2020 and beyond: Skip discrepancy between theory and practice of personalized medicine. a position paper by the Italian society of personalized medicine. Current Pharmaceutical Biotechnology, 17(10), 926-929.